2020

31 March 2021

ANNUAL FINANCIAL REPORT 31/12/2020

22 March 2021

2020 FY FINANCIAL RESULTS full version

22 March 2021

2020 FY ANALYSTS PRESENTATION

22 December 2020

Cetilar® Patch and Cetilar® Tape classified as Class 2A MD

The Higher Institute for Health (ISS) has classified Cetilar® Patch and Cetilar® Tape as Class 2A Medical Devices, while the U.S. […]

22 December 2020

CETILAR® PATCH AND CETILAR® TAPE CERTIFIED CLASS 2A MEDICAL DEVICES

15 December 2020

PharmaNutra enters the MTA market – STAR segment of Borsa Italiana

This morning saw the floating of shares in PharmaNutra S.p.A. on the MTA market – STAR segment of the Borsa […]

15 December 2020

MIDCAP INITIAL COVERAGE RESEARCH 15/12/2020

11 December 2020

BORSA ITALIANA ORDERS ADMISSION OF THE ORDINARY SHARES OF PHARMANUTRA TO TRADING ON THE MTA – STAR SEGMENT

11 December 2020

THE INFORMATION PROSPECTUS ON ADMISSION TO TRADING ON THE MTA – STAR SEGMENT HAS BEEN PUBLISHED

11 December 2020

CONSOB APPROVES THE INFORMATION PROSPECTUS FOR ADMISSION TO TRADING ON MTA – STAR SEGMENT

04 December 2020

BORSA ITALIANA DISPONE L’AMMISSIONE A QUOTAZIONE SUL MERCATO MTA DELLE AZIONI ORDINARIE DI PHARMANUTRA S.P.A.

01 December 2020

Partnership with the Zambon Group for the distribution of Sucrosomial® Iron in Brazil

PharmaNutra and Zambon extend their collaboration to introduce two new Sucrosomial® Iron-based products to the Brazilian market.   After the […]

01 December 2020

PHARMANUTRA S.P.A.: NEW DISTRIBUTION AGREEMENT FOR BRAZIL

25 November 2020

Alantra Research 11/11/2020

25 November 2020

Consolidated Financial Report 30/09/2020

18 November 2020

New international distribution agreement for Greece, Cyprus and Mauritius

The PharmaNutra Group will be present in Greece and Cyprus with its Cetilar® products, while SiderAL® Forte will be distributed […]

18 November 2020

PHARMANUTRA S.P.A.: NEW INTERNATIONAL DISTRIBUTION AGREEMENTS

11 November 2020

Registration of Cetilar® and SiderAL® trademarks granted in the USA

The American administrative body for patents, USPTO, communicates registration of the figurative and word marks of the two flagship PharmaNutra […]

11 November 2020

PHARMANUTRA S.P.A.: REGISTRATION OF THE BRANDS CETILAR® AND SIDERAL® GRANTED IN THE USA

09 November 2020

Consolidated financial report as at 30th September 2020

PharmaNutra S.p.A. communicates that the Board of Directors has examined and approved the consolidated financial report as at 30th September 2020, […]

09 November 2020

PHARMANUTRA S.P.A.: CONSOLIDATED FINANCIAL REPORT AS AT 30TH SEPTEMBER 2020